Epilepsy patients with the promotor UGT2B7 rs28365063 −161C > T genetic variant showed an increased clearance of the antiepileptic drug lamotrigine due to higher gene expression of the UGT2B7 enzyme [95]. Here, UGT2B7 is linked to epilepsy.